SBIR-STTR Award

A cloud-native, data-driven platform for automated quality assurance of radiation oncology treatment planning
Award last edited on: 10/14/2021

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$1,233,000
Award Phase
2
Solicitation Topic Code
DH
Principal Investigator
Michael R Bowers

Company Information

Oncospace Inc

1812 Ashland Avenue Suite 100
Baltimore, MD 21205
   (410) 236-5030
   info@oncospace.com
   www.oncospace.com
Location: Single
Congr. District: 07
County: Baltimore City

Phase I

Contract Number: 1913081
Start Date: 7/1/2019    Completed: 3/31/2020
Phase I year
2019
Phase I Amount
$225,000
This SBIR Phase I project will leverage the data generated routinely by radiation oncology practices to automate the peer-review process in which radiation oncologists evaluate the quality of planned treatments. Each cancer patient possesses a unique layout of normal anatomy relative to their disease and this impacts the characteristics of the treatment delivered. An example is that it is harder to achieve a low dose to an organ that is closer to the irradiated tumor. Today, quality evaluation for a planned treatment effectively assumes that the anatomical geometry of every patient with a given disease is the same. The proposed innovation personalizes the evaluation of radiotherapy treatment plans by comparing a patient's anatomy to thousands of past patients. The highest standards achieved are used as a yardstick for the current patient. Furthermore, plan evaluation is transformed from a subjective, error-prone, procedure to an efficient standardized process, including sophisticated anomaly detection. The benefit to the patient is lower doses to healthy organs and lower risk of their treatment being impacted by errors. This can reduce side effects and improve quality of life. The benefit to clinics is workflow efficiency and improved quality metrics, resulting in cost savings and proof of high practice standards. The proposed software product is an automated peer review system for radiation oncology treatment planning based on a large database of existing patient treatment plans. The unique strength of the innovation lies in it being based on a large and varied dataset that can provide reference patients to which the current patient can be meaningfully compared. During the treatment planning process, the system will allow radiation oncologists to detect anomalies in dose prescription and structure delineation, as well as obtain patient-specific dosimetric objectives against which to evaluate treatment plan quality. Machine learning approaches will be used for anomaly detection, where deviations from the norm will be flagged as requiring examination. Dosimetric objectives will be obtained using a search procedure that considers the geometric relationships between each targeted volume and each organ at risk. Automated peer-review will allow plan assessment during the treatment planning process itself rather than it being a retrospective step after the initiation of a patient's treatment course. Prospective review allows for customization based on individual patient characteristics and thus expands the role of peer review from quality assurance to the personalization of radiation treatments. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Phase II

Contract Number: 2035750
Start Date: 3/1/2021    Completed: 2/28/2023
Phase II year
2021
Phase II Amount
$1,008,000
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to improves patient outcomes in radiotherapy treatment. Healthcare providers are recognizing the growing imperative to lower costs and maintain quality of care by harnessing the digital health records available. In radiation oncology, only a small fraction of the valuable data produced during routine patient care is leveraged for the care of new patients. High-dose curative treatments frequently lead to side effects, such as dry mouth in head and neck cancer treatment, and rectal bleeding in prostate treatments. An optimized treatment plan could minimize complications. The proposed project will advance an information system to optimize and personalize radiation treatments. The proposed project leverages radiotherapy data to optimize treatment plans. Dose to organs at risk (OARs) must be kept low while ensuring the prescribed dosimetric coverage of the targeted disease. Intensity modulated radiotherapy (IMRT) treatments require significant optimization, creating extensive planning processes. This project will advance a treatment plan database for a data-driven clinical decision support solution that can predict achievable dose levels to each OAR. These levels can be used as intelligent optimization objectives by the treatment planning system (TPS) and as plan evaluation criteria. The system will be built for continuous refinement through ongoing augmentation with new patient plans, thus improving prediction performance with ongoing use, and allowing each clinical site to base predictions on its own data. In addition, integrated peer review tools enable physicians to efficiently share information and get additional clinical insight. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.